AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment.

[1]  A. Antinori,et al.  Aerosolized pentamidine, cotrimoxazole and dapsone‐pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis , 1995, AIDS.

[2]  J. Ragnaud,et al.  Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients , 1995, Journal of clinical microbiology.

[3]  D. Podzamczer,et al.  Twice-Weekly Maintenance Therapy with Sulfadiazine-Pyrimethamine To Prevent Recurrent Toxoplasmic Encephalitis in Patients with AIDS , 1995, Annals of Internal Medicine.

[4]  K. Holmes,et al.  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  L. Larocca,et al.  Evaluation of cerebrospinal fluid EBV‐DNA and IL‐10 as markers for in vivo diagnosis of AIDS‐related primary central nervous system lymphoma , 1995, British journal of haematology.

[6]  M. Vidaud,et al.  Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients , 1995, Journal of clinical microbiology.

[7]  B. Hirschel,et al.  Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. d’Arminio Monforte,et al.  Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions , 1994, AIDS.

[9]  J. Becker,et al.  Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. , 1994, Neurology.

[10]  M. Scerrati,et al.  Experience with brain biopsy in acquired immune deficiency syndrome‐related focal lesions of the central nervous system , 1994, The British journal of surgery.

[11]  L. Deangelis,et al.  Combined‐modality therapy in the treatment of primary central nervous system lymphoma in AIDS , 1994, Neurology.

[12]  É. Oksenhendler,et al.  Toxoplasma gondii infection in advanced HIV infection , 1994, AIDS.

[13]  J P Matts,et al.  Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. , 1994, The Journal of infectious diseases.

[14]  B. Luft,et al.  Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. , 1993, The New England journal of medicine.

[15]  A. Lazzarin,et al.  Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system , 1993, The Lancet.

[16]  M. Scerrati,et al.  Primary central nervous system lymphoma and brain biopsy in AIDS , 1993, The Lancet.

[17]  C. Gaudebout,et al.  Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. , 1993, The New England journal of medicine.

[18]  J. Galama,et al.  Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[20]  J. Phair,et al.  Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. , 1993, Journal of acquired immune deficiency syndromes.

[21]  M. Wallace,et al.  Cats and toxoplasmosis risk in HIV-infected adults. , 1993, JAMA.

[22]  H. Waskin,et al.  A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. , 1992, The New England journal of medicine.

[23]  M. Sande,et al.  Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.

[24]  A. Antinori,et al.  Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia , 1992, The Lancet.

[25]  J. Kovacs,et al.  Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS , 1992, The Lancet.

[26]  R. Glick,et al.  Diagnostic accuracy of AIDS-related CNS lesions. , 1992, Surgical neurology.

[27]  B. Guthrie,et al.  The role of stereotactic biopsy in the management of HIV-related focal brain lesions. , 1992, Neurosurgery.

[28]  J. Vuust,et al.  Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. , 1992, The Journal of infectious diseases.

[29]  B. Brody,et al.  The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. , 1992, Neurosurgery.

[30]  R. Penny,et al.  Trimethoprim‐sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS , 1992, AIDS.

[31]  B. Hirschel,et al.  Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. , 1991, Annals of internal medicine.

[32]  D. Israelski,et al.  Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis. , 1991, AIDS.

[33]  R. Lipton,et al.  The evaluation of patients with human immunodeficiency virus-related disorders and brain mass lesions. , 1991, Archives of internal medicine.

[34]  D. Cooper,et al.  Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis. , 1991, AIDS.

[35]  E. Aurelius,et al.  Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid , 1991, The Lancet.

[36]  M. Rosenblum,et al.  Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. , 1990, Journal of neurosurgery.

[37]  J. Boothroyd,et al.  Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid , 1990, Journal of clinical microbiology.

[38]  J. Rachlin,et al.  Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. , 1990, Journal of neurosurgery.

[39]  J. Miro,et al.  Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. , 1990, AIDS.

[40]  M. Rosenblum,et al.  Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. , 1990, AIDS.

[41]  J. Boothroyd,et al.  Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction , 1989, Journal of clinical microbiology.

[42]  R. Holzman,et al.  Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. , 1989, The American journal of medicine.

[43]  H. Haverkos.  Assessment of therapy for toxoplasma encephalitis. The TE Study Group. , 1987, The American journal of medicine.

[44]  B. Navia,et al.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients , 1986, Annals of neurology.

[45]  P. Morlat,et al.  Prévention primaire de la toxoplasmose cérébrale chez le sujet infecté par le VIH: résultats d'un essai randomisé en double insu, pyriméthamine versus placebo , 1993 .

[46]  D. Troost,et al.  Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS. , 1992, Journal of acquired immune deficiency syndromes.

[47]  D. Thomas,et al.  Stereotactic biopsy of cerebral lesions in patients with AIDS. , 1991, British journal of neurosurgery.

[48]  L. Weiss,et al.  Sensitive and specific detection of toxoplasma DNA in an experimental murine model: use of Toxoplasma gondii-specific cDNA and the polymerase chain reaction. , 1991, The Journal of infectious diseases.

[49]  C. Petito,et al.  Central nervous system lymphoma in the acquired immunodeficiency syndrome. , 1990, Clinical neuropathology.

[50]  B. Luft,et al.  AIDS commentary. Toxoplasmic encephalitis. , 1988, The Journal of infectious diseases.

[51]  C. Katlama,et al.  Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: Efficacy of long-term continuous therapy , 1988 .